Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Louis M. Staudt(National Cancer Institute), Philippe Gaulard(Inserm), Wing C. Chan(Ontario Institute for Cancer Research), Dennis D. Weisenburger(University of Nebraska Medical Center), Joseph M. Connors, Elı́as Campo(Hospital Clínic de Barcelona), Corinne Haïoun(Assistance Publique – Hôpitaux de Paris), Randy D. Gascoyne(BC Cancer Agency), John Powell(National Institutes of Health), Michael LeBlanc(Fred Hutch Cancer Center), Timothy C. Greiner(University of Nebraska Medical Center), Wyndham H. Wilson(National Institutes of Health), Karen Leroy, Jamés O. Armitage(University of Nebraska Medical Center), Emili Montserrat(Universitat de Barcelona), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Rita M. Braziel(Oregon Health & Science University), Julie M. Vose(University of Nebraska Medical Center), Jan Delabie, Michael Chiorazzi, Xin Yu(National Institutes of Health), George W. Wright(National Cancer Institute), Harald Holte(Oslo University Hospital), Elaine S. Jaffe(National Cancer Institute), Hong Zhao(National Institutes of Health), Liming Yang(China Three Gorges Corporation (China)), Richard Simon(University of Chicago), Thomas P. Miller(Queen Elizabeth University Hospital), James C. Lynch(University of Nebraska Medical Center), Richard D. Klausner(Memorial Sloan Kettering Cancer Center), Stein Kvaløy(Norwegian Cancer Society), Richard I. Fisher(University of Rochester), Hans Konrad Müller‐Hermelink(University of Würzburg), Thomas M. Grogan, Tong Zhao(Changzhou No.2 People's Hospital), Erlend B. Smeland(Norwegian Cancer Society), Armando López‐Guillermo(Barcelona Supercomputing Center)
The Journal of Experimental Medicine
September 15, 2003
Cited by 1,101


Related Papers